ProCE Banner Activity

CE / CME

Improving Outcomes in IgAN: Expert Guidance on Evolving Management and Treatment

Text Module

Learn more about emerging clinical data, guidelines, and regulatory approvals for patients with IgA nephropathy in this interactive text module. The activity features patient perspective audio clips, a pathogenesis animation, and accompanying downloadable slides to provide an informed approach to optimizing patient outcomes in IgAN.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurses: 1.00 Nursing contact hour

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: July 01, 2024

Expiration: June 30, 2025

Share

Faculty

Pietro Canetta

Pietro Canetta, MD, MS

Associate Professor of Medicine
Division of Nephrology
Columbia University Irving Medical Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC in partnership with American Kidney Fund

ProCE Banner

Supporters

Supported by educational grants from Novartis Pharmaceuticals Corporation and Otsuka America Pharmaceuticals.

Novartis Pharmaceuticals Corporation

Otsuka America Pharmaceuticals

Partners

American Kidney Fund

ProCE Banner

Target Audience

This program is intended for HCPs who care for patients with IgA nephropathy, including nephrology physicians, nurse practitioners, and physician associates.

Program Learning Goal

The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with IgA nephropathy.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Integrate IgAN pathogenesis, pathophysiology, and risk of disease progression into individualized decisions about patient care

  • Evaluate clinical efficacy and safety data for new and emerging IgAN therapies to formulate treatment plans that promote optimal patient outcomes

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Pietro Canetta, MD, MS

Associate Professor of Medicine
Division of Nephrology
Columbia University Irving Medical Center
New York, New York

Pietro Canetta, MD, MS: consultant/advisor/speaker: Novartis, Takeda; independent contractor: Otsuka.

The planners and content peer reviewers from Clinical Care Options, LLC and American Kidney Fund do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from July 01, 2024, through June 30, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO) and American Kidney Fund. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour.

Physician Associate Continuing Medical Education

LogoDescription automatically generated

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credit. Approval is valid until June 30, 2025. PAs should only claim credit commensurate with the extent of their participation.

CME Passport
662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.